At ESMO Congress 2019, starting from Friday 27 September in Barcelona, Spain, immunotherapy will confirm to continue to lead the global oncology scene with mature data from several trials being presented at the main sessions. Stefan Zimmermann, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland and Supervisor of the Daily Reporter, gives a preview of the hottest topics in the field.
Mature data from immunotherapy trials at ESMO 2019
